Literature DB >> 12420915

Management of portal hypertension.

S K Yachha1, Kamal Chetri, Richa Lal.   

Abstract

Portal hypertension (PHT) is common in children and a majority of cases in India are constituted by extrahepatic portal venous obstruction or cirrhosis of liver. Morbidity and mortality in this condition is related to variceal bleeding, most commonly from esophageal varices. Acute variceal bleeding is best controlled by endoscopic therapy. Somatostatin and octreotide are useful in acute variceal bleeding as a supplementary therapy. Acute variceal bleeding uncontrolled by medical therapy merits preferably a shunt surgery or devascularization depending upon etiology of PHT and expertise of the surgeon. Acute variceal bleeding originating from gastric varices can be effectively controlled by endoscopic injection of tissue adhesive agent (n-butyl 2 cyanoacrylate). Eradication of esophageal varices by endoscopic measures (sclerotherapy or band ligation) is successful in prevention of recurrence of bleeding. Surgical portosystemic shunts especially in non-cirrhotic PHT are successful in achieving portal decompression and significant reduction in recurrence of variceal bleeding. Role of beta-blockers in primary prophylaxis of variceal bleeding in children still remains to be substantiated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12420915     DOI: 10.1007/bf02723696

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  36 in total

1.  Non-cirrhotic portal fibrosis in children.

Authors:  U Poddar; B R Thapa; P Puri; C S Girish; K Vaiphei; R K Vasishta; K Singh
Journal:  Indian J Gastroenterol       Date:  2000 Jan-Mar

2.  Endoscopic sclerotherapy: the far and near effects.

Authors:  A Chaudhary; M Tatke; R C Aranya
Journal:  Br J Surg       Date:  1990-09       Impact factor: 6.939

3.  A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding.

Authors:  S K Sarin; R K Guptan; A K Jain; K R Sundaram
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-04       Impact factor: 2.566

4.  Endoscopic sclerotherapy for esophageal varices in children with extrahepatic portal venous obstruction: a follow-up study.

Authors:  S K Yachha; B C Sharma; M Kumar; A Khanduri
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-01       Impact factor: 2.839

5.  Endosonographic evaluation of the rectum in children with extrahepatic portal venous obstruction.

Authors:  S K Yachha; R K Dhiman; R Gupta; U C Ghoshal
Journal:  J Pediatr Gastroenterol Nutr       Date:  1996-11       Impact factor: 2.839

6.  Endoscopic ligation of esophageal varices in children.

Authors:  V L Fox; D L Carr-Locke; P J Connors; A M Leichtner
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-02       Impact factor: 2.839

7.  Portal obstruction in children. II. Results of surgical portosystemic shunts.

Authors:  F Alvarez; O Bernard; F Brunelle; P Hadchouel; M Odièvre; D Alagille
Journal:  J Pediatr       Date:  1983-11       Impact factor: 4.406

8.  Esophageal tamponade in the treatment of bleeding varices. A decadel progress report.

Authors:  M Chojkier; H O Conn
Journal:  Dig Dis Sci       Date:  1980-04       Impact factor: 3.199

9.  Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.

Authors:  K Oho; T Iwao; M Sumino; A Toyonaga; K Tanikawa
Journal:  Endoscopy       Date:  1995-06       Impact factor: 10.093

10.  Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding. Emergency control and prevention of early variceal rebleeding.

Authors:  A K Burroughs; P A McCormick; M D Hughes; D Sprengers; F D'Heygere; N McIntyre
Journal:  Gastroenterology       Date:  1990-11       Impact factor: 22.682

View more
  1 in total

1.  Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease.

Authors:  Kyoung Ah Lim; Sung Hye Kim; June Huh; I-Seok Kang; Heung Jae Lee; Tae-Gook Jun; Pyo Won Park
Journal:  J Korean Med Sci       Date:  2005-12       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.